Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Express Pharma
Our next phase of growth focuses on deepening technology adoption
MOVIN Express, through its specialised MOVIN Healthcare vertical is addressing needs with time-critical delivery solutions, validated temperature-controlled packaging and real-time shipment monitoring. Dr Dilip Sharma, Chief Operating Officer (COO), MOVIN Express, discusses how the company is transforming healthcare logistics and addressing the evolving needs of Indiaâs pharma industry The post Our next phase of growth focuses on deepening technology adoption appeared first on Express Pharma.
Read Full Article
Express Pharma
VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA
Calls for scientific validation of Ayurveda, highlights child health as a national priority The post VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA appeared first on Express Pharma.
Read Full Article
Pharma Tech
Rare disease regulation reaches âinflection pointâ with new FDA framework
The tailored framework arrives amid renewed focus on rare diseases across US health agencies.
Read Full Article
Express Pharma
Zydus launches Season 3 of âEasiest Examâ campaign to promote breast cancer awareness
The campaign will also feature oncologists sharing insights on early detection, timely screening and treatment, while highlighting the important role of caregiver The post Zydus launches Season 3 of âEasiest Examâ campaign to promote breast cancer awareness appeared first on Express Pharma.
Read Full Article
Pharma Tech
QCi and INmune Bio partner to study XPro in Alzheimerâs
INmune Bio and QCi have agreed to collaborate using quantum computing, AI, and data analytics to explore new indications for XPro, an investigational treatment for Alzheimer's disease and other medical conditions.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
PharmaShots
Oct 15, 2026, 12:30 PM
Rezolute Reports Enrollment Completion in P-III (upLIFT) Trial of Ersodetug in Tumor Hyperinsulinism
Shots: Ref: Globenewswire |  Image: Rezolute  | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Rezolute Reports Enrollment Completion in P-III (upLIFT) Trial of Ersodetug in Tumor Hyperinsulinism appeared first on PharmaShots.
PharmaShots
Oct 15, 2026, 11:30 AM
Ocugen and Roots Pharmaceutical Finalize OCU400 Licensing Deal for Retinitis Pigmentosa in MENA Region
Shots: Ref: Globenewswire |  Image: Ocugen & Roots Pharmaceutical | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Ocugen and Roots Pharmaceutical Finalize OCU400 Licensing Deal for Retinitis Pigmentosa in MENA Region appeared first on PharmaShots.
Express Pharma
Oct 15, 2026, 11:18 AM
Our next phase of growth focuses on deepening technology adoption
MOVIN Express, through its specialised MOVIN Healthcare vertical is addressing needs with time-critical delivery solutions, validated temperature-controlled packaging and real-time shipment monitoring. Dr Dilip Sharma, Chief Operating Officer (COO), MOVIN Express, discusses how the company is transforming healthcare logistics and addressing the evolving needs of Indiaâs pharma industry The post Our next phase of growth focuses on deepening technology adoption appeared first on Express Pharma.
Express Pharma
Oct 15, 2026, 11:02 AM
VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA
Calls for scientific validation of Ayurveda, highlights child health as a national priority The post VP inaugurates KAUMARACON-2026, launches digital initiatives at AIIA appeared first on Express Pharma.
Pharma Tech
Oct 15, 2026, 10:44 AM
Rare disease regulation reaches âinflection pointâ with new FDA framework
The tailored framework arrives amid renewed focus on rare diseases across US health agencies.
PharmaShots
Oct 15, 2026, 10:30 AM
Elevar Therapeutics Resubmits US FDA NDA for Camrelizumab + Rivoceranib to Treat 1L uHCC
Shots: Ref: Globenewswire |  Image: Elevar Therapeutics | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Elevar Therapeutics Resubmits US FDA NDA for Camrelizumab + Rivoceranib to Treat 1L uHCC appeared first on PharmaShots.
News
Latest industry coverage
Google News
Oct 15, 2026, 11:21 PM
Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate - Utah Business
Recursion prices $200M stock offering as Sanofi picks a partnered drug candidate  Utah Business
Google News
Oct 15, 2026, 11:01 PM
FTC and States Seek Contempt Finding Against Martin Shkreli Over Alleged Trading in at Least 60 Drug Stocks - Medical Daily
FTC and States Seek Contempt Finding Against Martin Shkreli Over Alleged Trading in at Least 60 Drug Stocks  Medical Daily
Google News
Oct 15, 2026, 10:29 PM
Pharmaceutical Scientists Unite to Translate Particle Engineering into Next-Generation Drug Dosage Forms - Bioengineer.org
Pharmaceutical Scientists Unite to Translate Particle Engineering into Next-Generation Drug Dosage Forms  Bioengineer.org
Google News
Oct 15, 2026, 10:00 PM
âAI lowers the capital neededâ: Indiaâs drug discovery push faces test of human trials - CNA
âAI lowers the capital neededâ: Indiaâs drug discovery push faces test of human trials  CNA
Google News
Oct 15, 2026, 9:16 PM
Global pharma firms walk back innovative drug investments in Japan - Nikkei Asia
Global pharma firms walk back innovative drug investments in Japan  Nikkei Asia
Google News
Oct 15, 2026, 9:08 PM
us judge bars copies of lilly weight-loss drug - BusinessWorld Online
us judge bars copies of lilly weight-loss drug  BusinessWorld Online
Google News
Oct 15, 2026, 8:50 PM
The Week in Health: IMSS Pay Dispute, Mental Health, and GLP-1 - Mexico Business News
The Week in Health: IMSS Pay Dispute, Mental Health, and GLP-1Â Â Mexico Business News
Google News
Oct 15, 2026, 8:44 PM
Doximity Settles Remaining OpenEvidence AI Prompt-Hack Dispute - Bloomberg Law News
Doximity Settles Remaining OpenEvidence AI Prompt-Hack Dispute  Bloomberg Law News
Google News
Oct 15, 2026, 8:36 PM
Systech Launches Automated Serialization Stations for Packaging Lines From: Systech International - Healthcare Packaging
Systech Launches Automated Serialization Stations for Packaging Lines From: Systech International  Healthcare Packaging
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer